JLRF Award

Ogimura Takashi Special Prize

Yasuhito Nannya: [Division of hematopoietic Disease Control, The Institute of Medical Science, The University of Tokyo]; “The role of cell surface molecule ‘Immunoglobulin superfamily 8(lgsf8)’ as a novel treatment target of acute myeloid leukemia”

Masahito Kato: [Department of Pediatrics, University of Tokyo Hospital]; “Investigation of molecular mechanism and novel therapeutic agents for atypical acute promyelocytic leukemia”

Goro Sashida: [International Research Center for Medical Science, Kumamoto University]; “Mechanism of numerical chromosomal abnormality-induced development of myelodysplastic syndrome”

Junji Koya: [Division of Molecular Oncology, National Cancer center Research Institute]; “Elucidation of the functional role of PD-L1 in B-cell lymphoma by multi-omics single-cell analysis”

Yoshihiko Kihara: [Laboratory for the development of therapies against MPN, Juntendo University Graduate School of Medicine]; “Development of therapies against myeloproliferative neoplasms with anti-mutant calreticulin antibody”
Koichi Oshima: [Department of Hematology-Oncology, Saitama Children’s Medical Center]; “Elucidation of the pathogenesis of primary myelofibrosis in children”

Akihide Yoshimi: [Cancer RNA Research Unit, National Cancer Center Research Institute]; “Novel antisense oligonucleotide therapeutics for leukemias”
Mariko Kinoshita: [Division of Pediatrics, Faculty of Medicine, University of Miyazaki Hospital]; “Mechanisms of drug resistance in childhood acute myeloid leukemia”
Daisuke Ennishi: [Department of Hematology and Oncology, Okayama University Hospital]; “The development of novel immunotherapies to target the genetic alterations regulating both intrinsic and extrinsic signals of lymphomas”
Hiroshi Kunimoto: [Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine]; “Investigating molecular basis for chemoresistance of high-risk leukemia using patient- derived leukemia model”

Kazuaki Kameda: [Division of Hematology, Jichi Medical University Saitama Medical Center]; “The role of tumor microenvironment in aggressive natural killer cell leukemia”
Manabu Wakamatsu: [Department of Pediatrics, Nagoya University Graduate School of Medicine]; “Epigenetic mechanisms mediated by histon modifications in JMML”
Kosuke Toyoda: [Department of Hematology, Rheumatology and Infectious Diseases, Faculty of Life Sciences, Kumamoto University]; “Elucidation of cancer metabolism driven by HTLV-1 towards identification of novel therapeutic targets for adult T-cell leukemia-lymphoma”
Shunsuke Nakagawa: [Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences]; “A new therapeutic strategy for pediatric acute myeloid leukemia using the nucleolus stress response”

JPLSG: [Japan Children’s Cancer Group]
Itaru Kato: [Department of Pediatrics, Kyoto University]; “Establishment of the basis for the multi omics single-cell analysis of lineage switched pediatric acute leukemia”